Met-157 in the active site of human glyoxalase I was changed by site-directed mutagenesis into alanine, glutamine or histidine in order to evaluate its possible role in catalysis. The glyoxalase I mutants were expressed in Escherichia coli and purified on an Shexylglutathione affinity gel. The physicochemical properties of the mutant proteins were similar to those of the wild-type enzyme. The glutamine mutant exhibited the same high specific activity as wild-type glyoxalase I, whereas the alanine and histidine mutants had approx. 20 % of wild-type activity. The k cat \K m values of the mutant glyoxalase I determined with the hemithioacetal adduct of glutathione and methylglyoxal were reduced to between 10 and 40 % of the wild-type value. This reduction was due to lower k cat values for the alanine and histidine mutants and a twofold increase in the K m value for the
INTRODUCTION
The glyoxalase system is of importance for detoxication of reactive 2-oxoaldehydes via their transformation into the corresponding non-toxic 2-hydroxy acids using glutathione as a cofactor [1] [2] [3] . Since 2-oxoaldehydes react with functional groups in essential biomolecules, such as guanyl nucleotides in nucleic
Figure 1 Schematic representation of active-site residues of human glyoxalase I
S-Benzylglutathione represents the ligand bound in the crystal structure [20] . The Zn 2 + is shown together with its five ligands, Gln-33, Glu-99, His-126, Glu-172 and water. The sulphur of the Met-157 is present 3n2 AH from the expected position of the C-1 of the S-substituent of the glutathione derivative. glutamine mutant. With the hemithioacetal of glutathione and phenylglyoxal, the kinetic parameters of the mutants were also of the same magnitude as those of wild-type glyoxalase I. Studies with the competitive inhibitors S-hexyl-and S-benzyl-glutathione revealed that the affinity was reduced to 7-11 % of the wild-type affinity for the glutamine and alanine mutants and to 30-40 % for the histidine mutant, as measured by a comparison of K i values. The results show that Met-157 has no direct role in catalysis, but is rather involved in forming the substrate-binding site of human glyoxalase I. The high activity of the glutamine mutant suggests that a structurally equivalent glutamine residue in the N-terminal half of Saccharomyces cere isiae glyoxalase I may be part of a catalytically competent active site.
acids to form imidazopurinone adducts [4] , and with cysteine, lysine and arginine residues in proteins [5] , it is obvious that elimination of these compounds may be essential to proper functioning of a cell. The pathophysiological correlates of certain diseases, e.g. diabetes, appear to be related to elevated levels of 2-oxoaldehydes [2] . The physiological substrates of glyoxalase I are assumed to be methylglyoxal, glyoxal and 4,5-dioxovalerate [1] [2] [3] . Methylglyoxal is formed as a by-product from the triosephosphate isomerase reaction in glycolysis [6] , from acetone in ketone body metabolism [7] and from aminoacetone in threonine catabolism [8] . Glyoxal is formed by lipid peroxidation and degradation of glucose and glycated proteins [9] . 4,5-Dioxovalerate is a metabolite deriving from the degradation of 4-aminolaevulinate [10] . The glyoxalase system is believed to be ubiquitous, and it has been found in most human tissues [11, 12] as well as in a wide variety of biological species.
The glyoxalase system is composed of two distinct enzymes [13] , glyoxalase I (EC 4.4.1.5 ; lactoylglutathione lyase) and glyoxalase II (EC 3.1.2.6 ; hydroxyacylglutathione hydrolase). Glyoxalase I catalyses the formation of S--lactoylglutathione from the hemithioacetal adduct formed spontaneously between methylglyoxal and GSH. S--Lactoylglutathione is a substrate for glyoxalase II, which hydrolyses the S-ester into -lactate and glutathione.
Human glyoxalase I is a dimer with a molecular mass of 43 kDa [14, 15] . Two allelic subunit variants differing in charge (residue 110), although with similar properties and function, have been found by purification of the enzyme from erythrocytes [16] and analysis of cDNA encoding glyoxalase I [17, 18] . Glyoxalase I requires Zn# + for its catalytic function [19] . The interaction of the protein with the metal has been elucidated in the three-dimensional crystal structure [20] , in which the metal is found to be bound to four amino acid side chains, two residues deriving from each of the two subunits. The Zn# + is believed to Amino acid 157 (Met) is the mutated active-site residue and amino acid 172 (Glu) is one of the ligands to the active-site Zn 2 + , as evidenced by the crystal structure of human glyoxalase I [20] . The yeast sequences S. cerevisiae and Schizosaccharomyces pombe can be divided into an N-and a C-terminal half, each apparently homologous to the human glyoxalase I subunit [25] . P. putida is Pseudomonas putida. Data came from the following references as indicated : a [14, 15, 17, 18] [24] .
be of importance for catalysis, which involves formation of an ene-diolate intermediate during the isomerization of the hemithioacetal adduct into the S-ester [21] . The suggested catalytic mechanism requires an active-site residue that can effect abstraction of the hydrogen from C-1 and deliver it to C-2. However, the crystal structure of glyoxalase I does not reveal any obvious candidate that could serve this function in the active site, except for the ligands of the metal. On the other hand, Met-157, the sulphur of which is only 3n2 A H away from C-1 in Sbenzylglutathione, a substrate and product analogue bound at the active site (Figure 1 ), may play a role in catalysis. This residue is conserved among several established primary structures of the enzyme and the putative glyoxalase I amino acid sequences from eukaryotes, except in the N-terminal half of the yeast Saccharomyces cere isiae, where a glutamine is present ( Figure 2 ) [20, 25] .
To study the influence of the conserved Met-157 on the activity of the enzyme, this amino acid in human glyoxalase I was mutated into alanine, glutamine and histidine. The glyoxalase I mutants were heterologously expressed in Escherichia coli, purified by affinity chromatography, and functionally characterized.
EXPERIMENTAL Materials
Enzymes used for PCR and recombinant DNA work were obtained from Boehringer-Mannheim (Mannheim, Germany). Oligonucleotides were custom-synthesized by Operon Technologies (Alameda, CA, U.S.A.). [α-$#P]dCTP and Sequenase version 2n0 were purchased from Amersham International (Amersham, Bucks., U.K.). Glutathione, methylglyoxal dimethyl acetal and phenylglyoxal were obtained from Sigma (St. Louis, MO, U.S.A.). Methylglyoxal was prepared by hydrolysis of the methylglyoxal dimethyl acetal, effected by boiling of the starting material in 10 % (v\v) H # SO % for 10 min [26] . S-Hexyl-and Sbenzyl-glutathione were synthesized as described previously [27] . Other chemicals were commercial products of the highest purity.
Site-directed mutagenesis via PCR
Mutagenesis was performed by PCR in a 100 µl reaction mixture containing 10 mM Tris\HCl, pH 8n3, 1n5 mM MgCl # , 50 mM KCl, 0n2 mM each dNTP, 0n8 µM 5h and 3h primers and 20 ng of template DNA. Human glyoxalase I cDNA inserted in the pKK-D vector [28] was used as a template in the reaction. Two consecutive PCRs were performed. In the first, the 5h part of the cDNA was amplified with a vector-specific primer pKKFor (5h-AAT TGT GAG CGG ATA ACA AT-3h) and the mutagenesis primers HGIM157A (5h-TGC CAG GCC TTT CGC TTT ACC ATC-3h) and HIM157QH (5h-TGC CAG GCC TTT STG TTT ACC ATC-3h, where S l G\C) for 20 cycles. The 3h part of the cDNA was subsequently amplified using an internal primer GI5A (5h-TTG AAT TCG AGT TGA CGC ATA ACT GGG G-3h) and a stop primer GIEXSTOP (5h-TAA GTC GAC TGC AGT TAT TAC ATT AAG GTT GCC ATT TTG TTA GG-3h).
The products of each PCR were combined (20 µl from each reaction mixture) and digested with the restriction endonuclease StuI, followed by ligation at 37 mC for 30 min. A second PCR with the primers pKKFor and HGIEXSTOP was carried out for 25 cycles with the ligated 5h and 3h parts of the glyoxalase I cDNA as template. The amplified 560 bp fragment was digested with EcoRI and SalI, ligated into the expression vector pKK-D, and transformed into E. coli JM109. All of the constructed mutants were sequenced [29] to verify that no unwanted mutations were present.
Expression and purification
The mutant forms of glyoxalase I were heterologously expressed in E. coli, cultured in the presence of 1 mM ZnSO % , as described previously [18] . The mutants were purified on S-hexylglutathione affinity gel and eluted with 5 mM S-hexylglutathione in 10 mM Tris\HCl, pH 7n8, containing 0n2 mM dithiothreitol. The previously estimated absorption coefficient at 280 nm for human glyoxalase I (1n68 ml:mg −" :cm −" ) was used to determine the protein concentration.
Physicochemical characterization
The relative molecular mass of the mutant proteins was estimated on precast SDS\8-20 % (w\v) polyacrylamide gels from Pharmacia Biotech using the PhastSystem. The protein bands were visualized by staining with silver.
Kinetic measurements
Enzyme activities were determined at 30 mC in a 1 ml reaction system consisting of 0n1 M sodium phosphate, pH 7n0, and 2 mM each of methylglyoxal and glutathione. The absorption coefficient at 240 nm used for monitoring S-ester formation was 3370 M −" :cm −" [13] . Kinetic constants were determined with the hemithioacetals of methylglyoxal and phenylglyoxal with GSH as substrate. The equilibrium constants for methylglyoxal and phenylglyoxal used for calculation of substrate and free GSH concentrations were 3n0 and 0n60 mM respectively [30] . The free GSH concentration was kept constant at 0n3 mM. Formation of the S-ester product S--lactoylglutathione was monitored at 240 nm, and formation of S-mandeloylglutathione at 263 nm (absorption coefficient 1100 M −" :cm −" ). The experimental data were analysed using the SIMFIT computer package [31] and Graphpad Prism 2n0 (GraphPad Software Inc., San Diego, CA, U.S.A.).
Inhibition studies
K i values were determined with the competitive inhibitors Shexyl-and S-benzyl-glutathione used in the micromolar concentration range. The adduct concentration of methylglyoxal and GSH was varied between 20 and 200 µM and the free GSH concentration was kept constant at 0n1 mM. The data were analysed using Graphpad Prism 2n0.
RESULTS

Expression of human glyoxalase I mutants
The glyoxalase I mutants containing alanine (M157A), histidine (M157H) and glutamine (M157Q) in position 157 were heterologously expressed in E. coli. All mutants had retained the ability to bind to the S-hexylglutathione gel [32] and were purified to homogeneity by affinity chromatography ; only a single band corresponding to a subunit of glyoxalase I was visible by SDS\PAGE analysis with silver staining. The yields of the mutant forms per litre of culture medium were 17 mg (M157A), 23 mg (M157H) and 16 mg (M157Q) after purification. All of the mutant proteins were obtained from E. coli cultured in the presence of 1 mM ZnSO % and were assumed to have incorporated Zn# + into the metal-binding site, since the mutations were not targeted towards any of the residues likely to affect the binding of the metal.
The purified mutant forms of glyoxalase I did not contain any unwanted spurious mutations, as verified by sequencing of the expressed cDNA sequences. Within experimental error the relative subunit molecular mass of the mutants was the same as that of the wild-type enzyme, determined to be 22 kDa by SDS\PAGE (results not shown). The isoelectric points of all mutant proteins except M157H were identical with the wild-type value of 4n8. The value for mutant M157H was 4n9 (results not shown).
All of the glyoxalase I mutants were catalytically active, and their specific activities are shown in Table 1 . The alanine and histidine mutants had specific activities that were approx. 5 times lower than the wild-type enzyme, as determined with the adduct of methylglyoxal and GSH. Interestingly, glutamine in position 157 of glyoxalase I resulted in a specific activity that even slightly exceeded that of the wild-type enzyme.
Determination of kinetic parameters and inhibition studies
Kinetic constants were determined by steady-state kinetic analysis with the GSH adducts of methylglyoxal and phenylglyoxal. The data were consistent with Michaelis-Menten kinetics. Table  1 shows the kinetic parameters obtained with the adduct of methylglyoxal and GSH as substrate and the concentration of free GSH at 0n3 mM. The k cat values, and the corresponding relative values as compared with the wild-type data, reflect the specific activity. The glutamine mutant retained the high k cat value of glyoxalase I. The K m value for the wild-type enzyme
Table 1 Kinetic constants of human glyoxalase I mutant forms determined with the hemithioacetal of GSH and methylglyoxal
Measurements were carried out in 1 ml of 0n1 M sodium phosphate, pH 7n0, at 30 mC. The concentration of free GSH was fixed at 0n3 mM. The k cat values are calculated per dimer (43 kD). Values are given as meanspS.D. estimated by non-linear regression analysis. In parentheses are the relative values compared with the wild-type value.
Glyoxalase I Specific activity (µmol:min
Wild-type 2340p260 (1) 1500p30 (1) 66p5 (1) 23 
S-Hexylglutathione 0n37p0n04 5n6p2 3 n 4 p 0 n 9 0n 88p0n08 S-Benzylglutathione 0n28p0n03 4n2p1 2 n 9 p 0 n 6 0n 85p0n07
was estimated at 66 µM. The values for the alanine and the histidine mutants were similar, whereas the K m value for the glutamine mutant was 2n5 times higher. The k cat \K m value of the wild-type enzyme (2n3i10 −( s −" :M −" ) was twice that of the glutamine mutant, whereas the histidine and alanine mutants had k cat \K m values that were 10 and 20 % of the wild-type value.
The pH-dependence of the k cat \K m values was also examined for the wild-type enzyme and the histidine mutant by taking measurements at pH 6n0, 7n0 and 8n0 (results not shown). Maximal activity was obtained at pH 7n0. No obvious difference in the pHdependence of the two enzyme forms was observed. k cat \K m values were also determined with the adduct of GSH and phenylglyoxal ( Table 2 ). The individual parameters k cat and K m could not be accurately estimated because of the high absorbance at high concentrations of the added phenylglyoxal. With this substrate, the glutamine mutant was 1n6-fold more efficient than wild-type glyoxalase I, whereas the alanine and histidine mutants were 2n5-fold less active.
The results of the inhibition studies with S-hexyl-and Sbenzyl-glutathione are shown in Table 3 . The glutamine mutant had K i values for the two inhibitors that were approximately 15-fold higher than those of the wild-type enzyme. In addition, the alanine mutant had a 9-10 times lower affinity for the glutathione derivatives. The histidine mutant had an affinity that was rather similar to that of the wild-type.
DISCUSSION
Although the three-dimensional structure of human glyoxalase I has been determined [20] , uncertainty about the residues directly involved in catalysis remains. In the present study the function of the active-site residue Met-157 was investigated by site-directed mutagenesis. The rationale behind the choice of Met-157 was the proximity of its sulphur atom to C-1 of the S-substituent of the ligand (Figure 1 ) and hence its possible involvement in catalysis. The proton bound to the corresponding C-1 of the hemithioacetal substrate is transferred to C-2 in the catalytic process. Further, this residue is conserved among several glyoxalase I sequences from eukaryotes. Met-157 was mutated into three alternative amino acids : alanine, histidine and glutamine. Alanine was chosen in order to remove the major part of the sidechain to see whether this extensive change would influence the functional properties of the enzyme. The histidine mutant was studied to find out whether the introduction of an imidazole group that could serve as a base would affect catalysis. Finally, the glutamine mutant was of interest, since glutamine is present in a structurally equivalent position in the N-terminal half of S. cere esiae glyoxalase I, as deduced by alignment of the amino acid sequences (Figure 2) . Glutamine also has a sidechain of similar length to that of methionine and introduces an amide group close to the reacting groups of the substrate.
The mutant proteins had physicochemical properties, including relative molecular mass, isoelectric points and binding of glutathione derivatives, similar to those of the wild-type glyoxalase I. The proteins appeared to be stable after purification and storage (j4 mC, 1 week), as indicated by their constant specific activities (not shown).
Glyoxalase I from yeast appears to have arisen by a tandem gene duplication such that the N-and C-terminal halves of the primary structure each correspond to a subunit of the human enzyme [20, 25] . The introduction of a glutamine in position 157 was of interest because of the presence of glutamine in the corresponding position in the aligned amino acid sequence of the N-terminal half of the yeast S. cere esiae. In all other eukaryotic glyoxalase I and presumed glyoxalase I sequences, a methionine is present in this position (Figure 2 ). In prokaryotes, the Met-157 appears to be replaced by serine or threonine. In the prokaryotic sequences, the serine or threonine is preceded by two extra residues, often including glycine, which are not present in the known eukaryotic sequences.
Interestingly, replacement of methionine with glutamine in position 157 of human glyoxalase I resulted in a fully functional enzyme. The K cat and specific activity values show that an equally or, with the phenylglyoxal adduct, even more efficient enzyme than the wild-type glyoxalase I was obtained. The demonstration of a catalytically fully competent human enzyme with glutamine in position 157 suggests that the monomeric glyoxalase I from S. cere esiae may have two different active sites, with methionine and glutamine present as alternative residues in the two positions structurally equivalent to human residue 157. In the other yeast species, Schizosaccharomyces pombe, methionine is present in both of the presumed active sites.
In this context it is noteworthy that the kinetic properties of glyoxalase I from S. cere isiae are similar to those of the human enzyme. For example, the yeast enzyme has a 1n4-fold higher catalytic efficiency (k cat \K m ) with phenylglyoxal than with methylglyoxal as substrate [3] . This substrate selectivity ratio is similar to the corresponding value (1n2) for the human wild-type enzyme [18] , which is augmented (to a 4n4-fold preference for phenylglyoxal) in the glutamine mutant (see Tables 1 and 2 ), as could be expected when both active sites contain this amino acid residue.
The present work shows that Met-157 in the active site of human glyoxalase I is not essential for catalytic activity, in spite of its almost complete conservation among known eukaryotic glyoxalase I sequences. The thioether group of the sidechain is probably without functional significance, since the carboxamido group of glutamine in mutant M157Q gives a k cat value similar to that of the wild-type enzyme. The histidine and alanine mutants display comparable kinetic parameters, somewhat more different from the wild-type values. The fact that truncating the amino acid sidechain to an alanine residue results in only a modest decrease in catalytic efficiency indicates that the sidechain of residue 157 has primarily a structural role in the active site. The sidechains of methionine and glutamine are of similar size, and it is possible that they may fulfil essentially the same role in shaping the active site for an optimal fit of the hemithioacetal moiety of the substrate to the active-site residues in the proximity of the Zn# + ion. The K i values of the competitive inhibitors measure binding properties of the active site, and show somewhat larger differences between the wild-type and mutant values than noted for k cat and K m values. Nevertheless, the k cat \K m values, which reflect transition-state stabilization, also suggest that a methionine residue in position 157 is optimal for catalysing the reaction with the natural substrate. The somewhat higher k cat \K m value noted with the glutamine mutant when the glutathione adduct of phenylglyoxal was used as substrate is probably not important from an evolutionary perspective, since phenylglyoxal is not known as a normal metabolite. In conclusion, it would appear that methionine has been conserved in position 157 in the active site of glyoxalase I, because it optimizes the interactions between the natural substrate and the functional groups of the active site.
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